Publication: Primary Aldosteronism: a Continuum from Normotension to Hypertension
3
Issued Date
2021-08-01
Resource Type
ISSN
15343170
15233782
15233782
Other identifier(s)
2-s2.0-85109063884
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Current Cardiology Reports. Vol.23, No.8 (2021)
Suggested Citation
Taweesak Wannachalee, Adina F. Turcu Primary Aldosteronism: a Continuum from Normotension to Hypertension. Current Cardiology Reports. Vol.23, No.8 (2021). doi:10.1007/s11886-021-01538-8 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/78007
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Primary Aldosteronism: a Continuum from Normotension to Hypertension
Author(s)
Other Contributor(s)
Abstract
Purpose of Review: Primary aldosteronism (PA) is the most common cause of secondary hypertension. Emerging evidence suggests that PA is associated with cardiovascular, metabolic, and renal complications, that likely develop insidiously, due to prolonged inappropriate mineralocorticoid receptor activation. In this review, we discuss the expanding clinical and pathological spectrum of PA. Recent Findings: Clinical and molecular studies conducted over the recent years reveal that PA traverses a series of contiguous stages. Pre-clinical, but hormonally overt PA has been identified in patients with normal blood pressure, and such patients harbor an increased risk of developing hypertension. Similarly, genetic and histopathological advancements have exposed a spectrum of PA pathology that corresponds to a continuum that spans from pre-clinical stages to florid PA. Summary: PA evolves from pre-hypertensive stages to resistant hypertension, along with serious cardiovascular and renal consequences. Early recognition of PA and targeted therapy will be essential for cardiovascular morbidity and mortality prevention in a large number of patients.